Nanotech Pharma Private Limited

Nanotech Pharma Private Limited - pharma in Bhiwandi, Maharashtra, India. FY 2026 financials and compliance.
CIN U24233MH2007PTC170530 Incorporated 03 May 2007 ROC Mumbai HQ Bhiwandi, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹2.45 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Last financials
Mar 2014
Balance sheet date

About Nanotech Pharma Private Limited

Data last updated: 25 February 2026

Nanotech Pharma Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 May 2007, the company has been in operation for over 19 years.

Registered with ROC Mumbai under CIN U24233MH2007PTC170530.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. Formerly known as Erica Remedies Private Limited. It is led by directors including Amarjeet Kumar Singh and Harish Kumar.

Last AGM: 30 September 2014. Financial statements filed for year ended 31 March 2014. Office: Cabin No. 1 Rehnal (Val) Village Bhiwandi Dist. Thane, Maharashtra, India – 421302.

As per MCA filings, the company has open charges of ₹2.45 Cr on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website nanotechpharma.ooo.

Company Details of Nanotech Pharma Private Limited
CIN U24233MH2007PTC170530
Registration Number 170530
Incorporation Date 03 May 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2014
Date of Balance Sheet 31 March 2014
Compliance Status Active Non-Compliant
Key People
Amarjeet Kumar Singh Director Harish Kumar Additional Director Sudhir Kumar Singh Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Cabin No. 1 Rehnal (Val) Village Bhiwandi Dist. Thane, Maharashtra, India – 421302
  • Industry
    Pharma, Drug Formulation & Development
Company report
Nanotech Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nanotech Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nanotech Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of Nanotech Pharma Private Limited

Nanotech Pharma Private Limited is currently managed by 3 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Amarjeet Kumar Singh Director 03 Nov 2014 11 Years 8 Months Current
Harish Kumar Additional Director 01 Jun 2018 8 Years 1 Months Current
Sudhir Kumar Singh
Also directs: Ne Care And Cure Hospitals Llp
Director 27 May 2013 13 Years 1 Months Current
View all directors

Financials of Nanotech Pharma Private Limited FY 2014 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Nanotech Pharma Private Limited

Open charges
₹2.45 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Bank of India₹2.45 Cr
Latest charge details
DateLenderAmountStatus
29 Jan 2015 Bank of India ₹2.45 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Nanotech Pharma Private Limited

View historical data on people associated with Nanotech Pharma Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Nanotech Pharma Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Nanotech Pharma Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Nanotech Pharma Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Nanotech Pharma Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Nanotech Pharma Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Nanotech Pharma Private Limited

MSME Payment Delays by Nanotech Pharma Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Nanotech Pharma Private Limited

Subsidiaries & Group Companies of Nanotech Pharma Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Nanotech Pharma Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Nanotech Pharma Private Limited

MCA Filings & Documents of Nanotech Pharma Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Nanotech Pharma Private Limited

Directors
01 Jun 2018
Harish Kumar was appointed as a Additional Director on 01 Jun 2018 & has been associated with this company since 8 years 1 month.
Charges
29 Jan 2015
A charge with Bank Of India amounted to Rs. 245.00 Lakh with Charge ID 10554088 was registered on 29 Jan 2015.
Directors
03 Nov 2014
Amarjeet Kumar Singh was appointed as a Director on 03 Nov 2014 & has been associated with this company since 11 years 8 months.
Activity
30 Sep 2014
Nanotech Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records.
Activity
31 Mar 2014
Nanotech Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai Ii.
Directors
27 May 2013
Sudhir Kumar Singh was appointed as a Director on 27 May 2013 & has been associated with this company since 13 years 1 month.

Frequently Asked Questions about Nanotech Pharma Private Limited

Nanotech Pharma Private Limited is an active private limited company in the pharma sector based in Bhiwandi, Maharashtra, India. It was incorporated on 03 May 2007 (19+ years old) and is registered under CIN U24233MH2007PTC170530.

The current directors of Nanotech Pharma Private Limited are:

The primary industry of Nanotech Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Nanotech Pharma Private Limited can be reached at the registered office: Cabin No. 1 Rehnal Val Village Bhiwandi Dist. Thane, Maharashtra, India – 421302, or through the website nanotechpharma.ooo.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹5 Lakh.

The company has its registered office at Cabin No. 1 Rehnal Val Village Bhiwandi Dist. Thane, Maharashtra, India – 421302.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available